Anatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with Tomotherapy

Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer

David M. Brizel, Todd H. Wasserman, Michael Henke et al. · Journal of Clinical Oncology · 2000 · 832 citations

Medicine, Oncology, Radiation Oncology +15

Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413

Mack Roach, Michelle DeSilvio, C.A. Lawton et al. · Journal of Clinical Oncology · 2003 · 639 citations

Medicine, Oncology, Radiation Oncology +17

Recommended Guidelines for the Treatment of Cancer Treatment-Induced Diarrhea

Al B. Benson, Jaffer A. Ajani, Robert B. Catalano et al. · Journal of Clinical Oncology · 2004 · 631 citations

Pharmacy, Oncology, Pharmacotherapy +17

RTOG GU Radiation Oncology Specialists Reach Consensus on Pelvic Lymph Node Volumes for High-Risk Prostate Cancer

C.A. Lawton, Jeff M. Michalski, Issam El Naqa et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 413 citations · Full text

Medicine, Radiation Oncology, Urology +14

Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer

Christopher M. Nutting, D. Convery, Vivian P. Cosgrove et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 230 citations

Medicine, Oncology, Radiation Oncology +16